Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Oncology reports, 38.2017, Nr. 6, S. 3291-3296, doi:10.3892/or.2017.6013
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2017
- Creator
-
Burger, Michael Christian
Ronellenfitsch, Michael Wilfried
Lorenz, Nadja I.
Wagner, Marlies
Voss, Martin
Capper, David
Tzaridis, Theophilos
Herrlinger, Ulrich
Steinbach, Joachim Peter
Stoffels, Gabriele
Langen, Karl-Josef
Brandts, Christian Hubertus
Senft, Christian Alexander
Harter, Patrick Nikolaus
Bähr, Oliver
- URN
-
urn:nbn:de:hebis:30:3-471650
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Burger, Michael Christian
- Ronellenfitsch, Michael Wilfried
- Lorenz, Nadja I.
- Wagner, Marlies
- Voss, Martin
- Capper, David
- Tzaridis, Theophilos
- Herrlinger, Ulrich
- Steinbach, Joachim Peter
- Stoffels, Gabriele
- Langen, Karl-Josef
- Brandts, Christian Hubertus
- Senft, Christian Alexander
- Harter, Patrick Nikolaus
- Bähr, Oliver
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2017
Other Objects (12)
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Expert consensus on re-irradiation for recurrent glioma
Expert consensus on re-irradiation for recurrent glioma
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
The role of oncogenic B-Raf in different aspects of malignant transformation
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
BRAF V600E mutations in nevi and melanocytic tumors of uncertain malignant potential (MELTUMPs)
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Expert consensus on re-irradiation for recurrent glioma
Expert consensus on re-irradiation for recurrent glioma
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
The role of oncogenic B-Raf in different aspects of malignant transformation
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
BRAF V600E mutations in nevi and melanocytic tumors of uncertain malignant potential (MELTUMPs)
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Expert consensus on re-irradiation for recurrent glioma
Expert consensus on re-irradiation for recurrent glioma
Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Hypoxia and Microvascular Alterations Are Early Predictors of IDH-Mutated Anaplastic Glioma Recurrence
The role of oncogenic B-Raf in different aspects of malignant transformation
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines